These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36017005)

  • 1. Dexmedetomidine to reduce vasopressor resistance in refractory septic shock: Protocol for a double-blind randomized controlled pilot trial (ADRESS Pilot study).
    Dargent A; Bourredjem A; Argaud L; Levy B; Fournel I; Cransac A; Badie J; Quintin L; Quenot JP
    Front Med (Lausanne); 2022; 9():968274. PubMed ID: 36017005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.
    Cioccari L; Luethi N; Bailey M; Shehabi Y; Howe B; Messmer AS; Proimos HK; Peck L; Young H; Eastwood GM; Merz TM; Takala J; Jakob SM; Bellomo R;
    Crit Care; 2020 Jul; 24(1):441. PubMed ID: 32678054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
    Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND
    Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial).
    Patel JJ; Willoughby R; Peterson J; Carver T; Zelten J; Markiewicz A; Spiegelhoff K; Hipp LA; Canales B; Szabo A; Heyland DK; Stoppe C; Zielonka J; Freed JK
    Chest; 2023 Feb; 163(2):303-312. PubMed ID: 36174744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.
    David S; Bode C; Stahl K;
    Trials; 2023 Apr; 24(1):277. PubMed ID: 37061693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial.
    Legrand M; Oufella HA; De Backer D; Duranteau J; Leone M; Levy B; Rossignol P; Vicaut E; Dépret F;
    Trials; 2020 Jul; 21(1):601. PubMed ID: 32611377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine for Reducing Mortality in Patients With Septic Shock A Randomized Controlled Trial (DecatSepsis).
    Ezz Al-Regal AR; Ramzy EA; Allah Atia AA; Emara MM
    Chest; 2024 Jul; ():. PubMed ID: 39004217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.
    Ibarra-Estrada M; Kattan E; Aguilera-González P; Sandoval-Plascencia L; Rico-Jauregui U; Gómez-Partida CA; Ortiz-Macías IX; López-Pulgarín JA; Chávez-Peña Q; Mijangos-Méndez JC; Aguirre-Avalos G; Hernández G
    Crit Care; 2023 Mar; 27(1):110. PubMed ID: 36915146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Non-Comparative Prospective Pilot Study of Ketamine for Sedation in Adult Septic Shock.
    Reese JM; Sullivan VF; Boyer NL; Mount CA
    Mil Med; 2018 Nov; 183(11-12):e409-e413. PubMed ID: 29800375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial.
    Petsakul S; Morakul S; Tangsujaritvijit V; Kunawut P; Singhatas P; Sanguanwit P
    BMC Anesthesiol; 2020 Nov; 20(1):280. PubMed ID: 33167911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of iloprost in patients with septic shock-induced endotheliopathy-Protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated trial.
    Bestle MH; Clausen NE; Søe-Jensen P; Kristiansen KT; Lange T; Johansson PI; Stensballe J; Perner A
    Acta Anaesthesiol Scand; 2020 May; 64(5):705-711. PubMed ID: 31950481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac arrest syndrome patients: study protocol for a randomized controlled trial.
    Meyer AS; Ostrowski SR; Kjaergaard J; Johansson PI; Hassager C
    Trials; 2016 Aug; 17():378. PubMed ID: 27484224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial.
    Bokoch MP; Tran AT; Brinson EL; Marcus SG; Reddy M; Sun E; Roll GR; Pardo M; Fields S; Adelmann D; Kothari RP; Legrand M
    BMJ Open; 2023 Nov; 13(11):e078713. PubMed ID: 37984940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial.
    Cocchi MN; Dargin J; Chase M; Patel PV; Grossestreuer A; Balaji L; Liu X; Moskowitz A; Berg K; Donnino MW
    Shock; 2022 Apr; 57(4):508-517. PubMed ID: 35066509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.
    Laterre PF; Berry SM; Blemings A; Carlsen JE; François B; Graves T; Jacobsen K; Lewis RJ; Opal SM; Perner A; Pickkers P; Russell JA; Windeløv NA; Yealy DM; Asfar P; Bestle MH; Muller G; Bruel C; Brulé N; Decruyenaere J; Dive AM; Dugernier T; Krell K; Lefrant JY; Megarbane B; Mercier E; Mira JP; Quenot JP; Rasmussen BS; Thorsen-Meyer HC; Vander Laenen M; Vang ML; Vignon P; Vinatier I; Wichmann S; Wittebole X; Kjølbye AL; Angus DC;
    JAMA; 2019 Oct; 322(15):1476-1485. PubMed ID: 31577035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial.
    Mondardini MC; Sperotto F; Daverio M; Caramelli F; Gregori D; Caligiuri MF; Vitale F; Cecini MT; Piastra M; Mancino A; Pettenazzo A; Conti G; Amigoni A
    Trials; 2019 Dec; 20(1):710. PubMed ID: 31829274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.